Greenland Mines (GRML)
Market Price (9/14/2026): $3.16 | Market Cap: $8.0 MilSector: Materials | Industry: Precious Metals & Minerals
Greenland Mines (GRML)
Market Price (9/14/2026): $3.16Market Cap: $8.0 MilSector: MaterialsIndustry: Precious Metals & Minerals
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
Cash is significant % of market capNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -113% Megatrend and thematic driversMegatrends include Battery Technology & Metals. Themes include Rare Earth Elements. | Very low revenueRev LTMTotal Revenue or Sales, Last Twelve Months is 0 Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -18 Mil Stock price has recently run up significantly6M Rtn6 month market price return is 668%, 12M Rtn12 month market price return is 573% Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -302% High stock price volatilityVol 12M is 9561% Significant short interestShort Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 25% |
| Cash is significant % of market capNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -113% |
| Megatrend and thematic driversMegatrends include Battery Technology & Metals. Themes include Rare Earth Elements. |
| Very low revenueRev LTMTotal Revenue or Sales, Last Twelve Months is 0 |
| Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -18 Mil |
| Stock price has recently run up significantly6M Rtn6 month market price return is 668%, 12M Rtn12 month market price return is 573% |
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -302% |
| High stock price volatilityVol 12M is 9561% |
| Significant short interestShort Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 25% |
Qualitative Assessment
AI Analysis | Feedback
Greenland Mines (GRML) stock has lost about 80% since 5/31/2026 because of the following key factors:
1. Continued Financial Losses and Pre-Revenue Status: Greenland Mines (GRML) reported a net loss of $3.69 million for fiscal Q2 2026, which ended on June 30, 2026, and remained a pre-revenue company. The net loss for the six months ending June 30, 2026, significantly increased to $17.54 million, compared to $6.33 million in the prior year period, raising investor apprehension due to persistent unprofitability.
2. Implementation of a Reverse Stock Split: A 1-for-50 reverse stock split became effective on August 24, 2026. This action was primarily aimed at meeting Nasdaq's minimum bid price requirement, which the market often interprets as a negative indicator signaling fundamental issues or a struggle to maintain listing standards.
Show more
Greenland Mines (GRML) stock has lost about 80% since 5/31/2026 because of the following key factors:
1. Continued Financial Losses and Pre-Revenue Status: Greenland Mines (GRML) reported a net loss of $3.69 million for fiscal Q2 2026, which ended on June 30, 2026, and remained a pre-revenue company. The net loss for the six months ending June 30, 2026, significantly increased to $17.54 million, compared to $6.33 million in the prior year period, raising investor apprehension due to persistent unprofitability.
2. Implementation of a Reverse Stock Split: A 1-for-50 reverse stock split became effective on August 24, 2026. This action was primarily aimed at meeting Nasdaq's minimum bid price requirement, which the market often interprets as a negative indicator signaling fundamental issues or a struggle to maintain listing standards.
3. Shareholder Rights Plan and Meeting Adjournments: On July 23, 2026, Greenland Mines adopted a limited-duration shareholder rights plan, also known as a "poison pill," which led to a 9.85% decline in GRML's stock price on that day. Additionally, the repeated adjournment of a special meeting of stockholders, originally scheduled for July 16, 2026, and then to August 7, 2026, and September 3, 2026, created prolonged uncertainty among investors regarding key strategic decisions.
4. Planned Public Offering for Funding: The company announced a planned $20 million public offering to fund the cash component of the Sarfartoq acquisition. This anticipated equity raise likely contributed to investor concerns about potential share dilution, placing further downward pressure on the stock price during the period.
Show less
Stock Movement Drivers
Fundamental Drivers
The -82.3% change in GRML stock from 5/31/2026 to 9/13/2026 was primarily driven by a -22.7% change in the company's Shares Outstanding (Mil).| (LTM values as of) | 5312026 | 9132026 | Change |
|---|---|---|---|
| Stock Price ($) | 17.80 | 3.15 | -82.3% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | � | � | 0.0% |
| Net Income Margin (%) | � | � | 0.0% |
| P/E Multiple | � | � | 0.0% |
| Shares Outstanding (Mil) | 2 | 2 | -22.7% |
| Cumulative Contribution | 0.0% |
Market Drivers
5/31/2026 to 9/13/2026| Return | Correlation | |
|---|---|---|
| GRML | -82.3% | |
| Market (SPY) | 1.0% | 7.9% |
| Sector (XLB) | -0.4% | 27.0% |
Fundamental Drivers
nullnull
Market Drivers
2/28/2026 to 9/13/2026| Return | Correlation | |
|---|---|---|
| GRML | ||
| Market (SPY) | 11.7% | 3.7% |
| Sector (XLB) | -4.2% | 10.3% |
Fundamental Drivers
nullnull
Market Drivers
8/31/2025 to 9/13/2026| Return | Correlation | |
|---|---|---|
| GRML | ||
| Market (SPY) | 19.5% | 3.7% |
| Sector (XLB) | 12.0% | 10.3% |
Fundamental Drivers
nullnull
Market Drivers
8/31/2023 to 9/13/2026| Return | Correlation | |
|---|---|---|
| GRML | ||
| Market (SPY) | 75.7% | 3.7% |
| Sector (XLB) | 29.7% | 10.3% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| GRML Return | - | - | - | - | - | 716% | 716% |
| Peers Return | 26% | -8% | -14% | -5% | 8068% | 12% | 8608% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 11% | 102% |
Monthly Win Rates [3] | |||||||
| GRML Win Rate | - | - | - | - | - | 43% | |
| Peers Win Rate | 35% | 47% | 37% | 38% | 65% | 49% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 44% | |
Max Drawdowns [4] | |||||||
| GRML Max Drawdown | - | - | - | - | - | - | |
| Peers Max Drawdown | -35% | -42% | -36% | -35% | -42% | -48% | |
| S&P 500 Max Drawdown | -5% | -25% | -10% | -8% | -19% | -9% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: PLG, MP, USAR, NEM, GOLD.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 9/11/2026 (YTD)
How Low Can It Go
GRML has limited trading history. Below is the Materials sector ETF (XLB) in its place.
| Event | XLB | S&P 500 |
|---|---|---|
| 2025 US Tariff Shock | ||
| % Loss | -17.0% | -18.8% |
| % Gain to Breakeven | 20.5% | 23.1% |
| Time to Breakeven | 84 days | 79 days |
| Summer-Fall 2023 Five Percent Yield Shock | ||
| % Loss | -12.5% | -9.5% |
| % Gain to Breakeven | 14.3% | 10.5% |
| Time to Breakeven | 52 days | 24 days |
| 2022 Inflation Shock & Fed Tightening | ||
| % Loss | -23.5% | -24.5% |
| % Gain to Breakeven | 30.7% | 32.4% |
| Time to Breakeven | 456 days | 427 days |
| 2020 COVID-19 Crash | ||
| % Loss | -36.2% | -33.7% |
| % Gain to Breakeven | 56.8% | 50.9% |
| Time to Breakeven | 114 days | 140 days |
| Q4 2018 Fed Policy Error / Growth Scare | ||
| % Loss | -18.3% | -19.2% |
| % Gain to Breakeven | 22.4% | 23.8% |
| Time to Breakeven | 101 days | 105 days |
| 2015-2016 China Devaluation / Global Growth Scare | ||
| % Loss | -17.9% | -12.2% |
| % Gain to Breakeven | 21.7% | 13.9% |
| Time to Breakeven | 52 days | 62 days |
In The Past
State Street Materials Select Sector SPDR ETF's stock fell -17.0% during the 2025 US Tariff Shock. Such a loss loss requires a 20.5% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
GRML has limited trading history. Below is the Materials sector ETF (XLB) in its place.
| Event | XLB | S&P 500 |
|---|---|---|
| 2022 Inflation Shock & Fed Tightening | ||
| % Loss | -23.5% | -24.5% |
| % Gain to Breakeven | 30.7% | 32.4% |
| Time to Breakeven | 456 days | 427 days |
| 2020 COVID-19 Crash | ||
| % Loss | -36.2% | -33.7% |
| % Gain to Breakeven | 56.8% | 50.9% |
| Time to Breakeven | 114 days | 140 days |
| 2014-2016 Oil Price Collapse | ||
| % Loss | -23.8% | -6.8% |
| % Gain to Breakeven | 31.2% | 7.3% |
| Time to Breakeven | 171 days | 15 days |
| 2011 US Debt Ceiling Crisis & European Contagion | ||
| % Loss | -28.2% | -17.9% |
| % Gain to Breakeven | 39.3% | 21.8% |
| Time to Breakeven | 459 days | 123 days |
| 2008-2009 Global Financial Crisis | ||
| % Loss | -56.6% | -53.4% |
| % Gain to Breakeven | 130.3% | 114.4% |
| Time to Breakeven | 701 days | 1085 days |
In The Past
State Street Materials Select Sector SPDR ETF's stock fell -17.0% during the 2025 US Tariff Shock. Such a loss loss requires a 20.5% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About Greenland Mines (GRML)
Greenland Mines (GRML), operating as Klotho Neurosciences, Inc., is a biopharmaceutical company dedicated to developing innovative therapies and specialty diagnostics. Its core focus is on addressing neurological and age-related disorders, with a mission to mitigate severe conditions such as dementia symptoms, Alzheimer's disease, and various neuromuscular diseases.
The company's product portfolio is diverse, featuring advanced cell and gene therapies aimed at enhancing longevity and reducing age-related pathologies. Additionally, GRML develops biologics and biosimilars primarily for the treatment of cancer, alongside research into melanocortin receptors. A significant aspect of its research and development involves a strategic partnership with Japan's Okinawa Research Center, specifically for Klotho gene therapy focused on extending longevity and combating age-related illnesses.
Greenland Mines (GRML) primarily serves patient populations affected by neurological and age-related disorders, as well as individuals undergoing cancer treatment. Its efforts position the company within critical healthcare markets focused on improving quality of life and extending healthy lifespans through cutting-edge biomedical solutions.
AI Analysis | Feedback
AI Analysis | Feedback
AI Analysis | Feedback
AI Analysis | Feedback
AI Analysis | Feedback
AI Analysis | Feedback
AI Analysis | Feedback
AI Analysis | Feedback
- Precious Metals (Palladium, Gold, Platinum): The company's Skaergaard Project in Southeast Greenland holds significant resources, with an estimated gross undiscounted in-situ metal value of approximately $68 billion based on February 2026 metal prices. While this represents resource value rather than an annual market, it indicates the scale of the underlying commodity markets. Globally, the precious metals market is extensive.
- Rare Earth Elements (Neodymium, Praseodymium): Greenland Mines is expanding its critical minerals platform to include rare earths. The global rare earth elements market was valued at $10.19 billion in 2023 and is projected to reach $20.50 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.20%. This market includes vital components for electric vehicle motors, wind turbines, and advanced electronics.
- Cell and Gene Therapies for Neurodegenerative Disorders: Greenland Mines is involved in the development of gene therapies using the Klotho protein for neurodegenerative diseases like ALS. The global cell and gene therapy market was valued at $18.61 billion in 2023 and is expected to grow to $203.26 billion by 2033, demonstrating a CAGR of 26.6%. Specifically, the global market for Alzheimer's disease therapeutics was valued at $6.7 billion in 2023 and is projected to reach $17.8 billion by 2033, with a CAGR of 10.3%. The anti-aging products market, related to Klotho's longevity aspects, was valued at $14.05 billion in the U.S. in 2024 and is forecasted to reach $27.44 billion by 2033, with a CAGR of 8.0%. Globally, the anti-aging market is expected to surpass $421.4 billion in revenue by 2030, with an 8.1% CAGR.
- Biosimilars for Cancer Treatment: The company's biotechnology segment includes a biosimilar biologics platform for treating cancer. The global oncology biosimilars market size was valued at $4.49 billion in 2023 and is projected to grow to $28.31 billion by 2033, exhibiting a CAGR of 20.32%.
AI Analysis | Feedback
AI Analysis | Feedback
Peer Outperformance in Precious Metals & Minerals
null| Industry | Names | 1Y med | 3Y med | 5Y med | Top 3 by 5Y |
|---|---|---|---|---|---|
| Copper | 7 | 73.5% | 86.3% | 292.5% | COPR 1050% · TGB 338% · HBM 335% |
| Steel | 13 | 27.6% | 45.6% | 163.1% | HCC 344% · NWPX 323% · AMR 322% |
| Silver | 6 | 106.1% | 332.7% | 149.9% | AYA 258% · HL 228% · SVM 182% |
| Gold | 34 | 28.2% | 196.7% | 148.9% | IAG 755% · CNL 485% · KGC 445% |
| Aluminum | 3 | 68.8% | 117.1% | 61.8% | CENX 246% · KALU 62% · AA 6% |
| Construction Materials | 7 | -20.5% | 19.6% | 49.7% | USLM 352% · CRH 82% · SMID 54% |
| Diversified Metals & Mining | 23 | -13.3% | 1.6% | 18.8% | ATLX 216329% · USAR 52115% · TII 699% |
| Metal, Glass & Plastic Containers | 10 | -6.3% | 10.6% | 5.6% | KRT 167% · MYE 67% · GEF 49% |
| Paper & Plastic Packaging Products & Materials | 7 | 4.5% | 4.7% | -11.8% | PKG 82% · CCK 13% · SON -7% |
| Specialty Chemicals | 41 | 7.4% | -4.2% | -13.0% | ODC 461% · NEU 202% · CMT 91% |
| Commodity Chemicals | 12 | 18.6% | -14.4% | -23.8% | HWKN 275% · MEOH 76% · LXU 72% |
| Diversified Chemicals | 4 | -2.5% | -28.5% | -28.8% | CBT 78% · ASH -15% · CC -43% |
| Precious Metals & Minerals ← | 8 | 38.9% | 181.8% | -31.3% | ASM 599% · PPTA 390% · MTA 37% |
| Fertilizers & Agricultural Chemicals | 10 | -5.6% | -5.7% | -31.7% | CF 220% · CTVA 110% · NTR 53% |
| Paper Products | 3 | -20.3% | -51.3% | -96.0% | CLW -39% · MERC -96% · ITP -96% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 31.89 |
| Mkt Cap | 3.6 |
| Rev LTM | 13 |
| Op Inc LTM | -18 |
| FCF LTM | -16 |
| FCF 3Y Avg | -53 |
| CFO LTM | -15 |
| CFO 3Y Avg | -25 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 25.7% |
| Rev Chg 3Y Avg | 18.0% |
| Rev Chg Q | 52.0% |
| QoQ Delta Rev Chg LTM | 20.1% |
| Op Inc Chg LTM | 7.3% |
| Op Inc Chg 3Y Avg | 3.5% |
| Op Mgn LTM | -34.1% |
| Op Mgn 3Y Avg | -10.2% |
| QoQ Delta Op Mgn LTM | 16.9% |
| CFO/Rev LTM | -27.5% |
| CFO/Rev 3Y Avg | 10.6% |
| FCF/Rev LTM | -165.2% |
| FCF/Rev 3Y Avg | -52.7% |
Price Behavior
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | 160.75 | 78.75 | 40.19 | -74.74 | -26.31 | -6.07 |
| Up Beta | -376.59 | -186.07 | -120.72 | -183.49 | -198.61 | -173.97 |
| Down Beta | -2.67 | -3.90 | 0.15 | 1.03 | -0.29 | 1.57 |
| Up Capture | 43826% | 20878% | -217% | 6676% | 3044% | 288% |
| Bmk +ve Days | 10 | 21 | 32 | 68 | 138 | 427 |
| Stock +ve Days | 3 | 8 | 16 | 38 | 38 | 38 |
| Down Capture | 608% | 333% | 247% | 245% | 154% | 85% |
| Bmk -ve Days | 11 | 21 | 32 | 59 | 113 | 324 |
| Stock -ve Days | 4 | 10 | 24 | 56 | 56 | 56 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with GRML | |
|---|---|---|---|---|
| GRML | -86.2% | 7,661.2% | 1.50 | - |
| Sector ETF (XLB) | 14.0% | 17.9% | 0.58 | -3.0% |
| Equity (SPY) | 18.3% | 12.8% | 1.03 | 2.0% |
| Gold (GLD) | 19.0% | 29.2% | 0.59 | 8.7% |
| Commodities (DBC) | 48.3% | 20.6% | 1.80 | -6.9% |
| Real Estate (VNQ) | 7.6% | 13.6% | 0.29 | -9.3% |
| Bitcoin (BTCUSD) | -32.4% | 43.8% | -0.77 | -0.1% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with GRML | |
|---|---|---|---|---|
| GRML | -32.6% | 7,661.2% | 1.50 | - |
| Sector ETF (XLB) | 5.5% | 19.1% | 0.18 | -3.0% |
| Equity (SPY) | 12.5% | 17.2% | 0.55 | 2.0% |
| Gold (GLD) | 18.7% | 18.8% | 0.81 | 8.7% |
| Commodities (DBC) | 11.4% | 19.5% | 0.46 | -6.9% |
| Real Estate (VNQ) | 0.7% | 18.9% | -0.07 | -9.3% |
| Bitcoin (BTCUSD) | 9.4% | 52.6% | 0.36 | -0.1% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with GRML | |
|---|---|---|---|---|
| GRML | -17.9% | 7,661.2% | 1.50 | - |
| Sector ETF (XLB) | 9.8% | 20.7% | 0.42 | -3.0% |
| Equity (SPY) | 15.2% | 17.9% | 0.72 | 2.0% |
| Gold (GLD) | 12.3% | 16.3% | 0.62 | 8.7% |
| Commodities (DBC) | 8.7% | 18.1% | 0.39 | -6.9% |
| Real Estate (VNQ) | 4.7% | 20.7% | 0.19 | -9.3% |
| Bitcoin (BTCUSD) | 63.2% | 66.2% | 1.03 | -0.1% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Earnings Returns History
Updated 6/3/2026| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| SUMMARY STATS | |||
| # Positive | 0 | 0 | 0 |
| # Negative | 0 | 0 | 0 |
| Median Positive | |||
| Median Negative | |||
| Max Positive | |||
| Max Negative | |||
| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| SUMMARY STATS | |||
| # Positive | 0 | 0 | 0 |
| # Negative | 0 | 0 | 0 |
| Median Positive | |||
| Median Negative | |||
| Max Positive | |||
| Max Negative | |||
Insider Activity
Updated 7/23/2026| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Sawyer, Jason David | Direct | Buy | 7232026 | 0.23 | 240,000 | 55,944 | 55,944 | Form | |
| 2 | McGarity, Jon | Direct | Buy | 7202026 | 0.18 | 140,000 | 24,822 | 97,741 | Form | |
| 3 | Leblanc, Jeff | Chief Financial Officer | Direct | Buy | 7172026 | 0.18 | 1,400,000 | 245,280 | 844,524 | Form |
| 4 | El-Dada, Riad Hussein | Direct | Sell | 6252026 | 0.23 | 175,000 | 40,548 | 40,548 | Form |
| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Sawyer, Jason David | Direct | Buy | 7232026 | 0.23 | 240,000 | 55,944 | 55,944 | Form | |
| 2 | McGarity, Jon | Direct | Buy | 7202026 | 0.18 | 140,000 | 24,822 | 97,741 | Form | |
| 3 | Leblanc, Jeff | Chief Financial Officer | Direct | Buy | 7172026 | 0.18 | 1,400,000 | 245,280 | 844,524 | Form |
| 4 | El-Dada, Riad Hussein | Direct | Sell | 6252026 | 0.23 | 175,000 | 40,548 | 40,548 | Form |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.